Alkaloids: of ephedrine and their derivatives: norephedrine and its salts

In 2024, alkaloids: of ephedrine and their derivatives: norephedrine and its salts trade exhibited significant decline, with global flows reaching $4,774,730 and a three-year compound annual growth rate of +5.9% (five-year: +0.8%). The all-time peak of $11,322,560 was recorded in 1995; the current level is 58% below that high-water mark.

Over the 30-year observation window (1995–2024), 41% of years recorded positive growth, indicating significant cyclicality with frequent contractions. Trend momentum is strengthening (+4.8% acceleration).

The supply side is concentrated (Herfindahl-Hirschman Index 0.474). The three largest exporters — Taiwan ($5.0M), India ($2.3M), and Japan ($2.1M) — collectively dominate supply flows. The leading exporter has grown at +10.7% over the last three years.

On the demand side, importer concentration is moderately concentrated (HHI 0.200). The three largest import markets are Indonesia ($1.5M), United States ($1.3M), and Denmark ($585.5K). The largest importing market sources from 5 different supplying countries.

The dominant trade corridor is Taiwan → Indonesia at $1.5M, representing 99.8% of the importer's total demand.

The volatility score for alkaloids: of ephedrine and their derivatives: norephedrine and its salts is 12 out of 100, classified as low. Trade flows are relatively stable compared to other HS6 products, suggesting mature supply chains and predictable demand.

For market entrants, contracting demand signals caution before committing resources. The concentrated supply structure suggests high barriers but also potential opportunity if dominant suppliers face disruption or capacity constraints.

Data confidence is rated "High" based on reporting coverage and consistency across OECD member and partner countries.